Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT07368634 · RECRUITING

Trial details

NCT number: NCT07368634
Sponsor: Daihong Liu
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epstein-Barr Virus Infection Post-Transplant Lymphoproliferative Disorder

Start date: 2025-06-01
Primary completion: 2027-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.